Staphylococcus Aureus Bacteraemia (SAB)-Support-Study

Last updated: January 31, 2024
Sponsor: University Medicine Greifswald
Overall Status: Active - Recruiting

Phase

N/A

Condition

Soft Tissue Infections

Staphylococcal Infections

Sepsis And Septicemia

Treatment

Checklist-based phone calls

Clinical Study ID

NCT06249451
BB 140/23
  • Ages > 18
  • All Genders

Study Summary

The main objective of this study is to investigate whether checklist-based close telephone consultation and process surveillance for S. aureus bacteraemia (SAB) can improve adherence to our in-house SAB-guidelines (prospective quality- improvement group).

In addition, the effects of telephone consultation on the clinical outcome of patients will be examined.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • ≥ 18 years
  • Inpatient treatment at the University Medicine Greifswald university hospital
  • First diagnosis of SAB in hospital

Exclusion

Exclusion Criteria:

  • SAB already known before admission
  • Palliative management within 48 hrs after SAB diagnosis
  • Death within 48 hrs after SAB diagnosis
  • Hospital discharge within 48hrs after SAB diagnosis

Study Design

Total Participants: 124
Treatment Group(s): 1
Primary Treatment: Checklist-based phone calls
Phase:
Study Start date:
January 22, 2024
Estimated Completion Date:
April 23, 2025

Connect with a study center

  • Greifswald University Medicine

    Greifswald,
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.